✦ LIBER ✦

Immune events following immunoablative therapy for the treatment of multiple sclerosis (MS)

✍ Scribed by H. Atkins; M. Freedman; M. Bowman; A. Bar-Or; R. Cheynier; R. Corsini; F. Jalili; H.J. Kim; L. Miller; R. Sekaly

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunoablative therapy with autologous s

✍ T Kozák; E Havrdová; J Pit’ha; E Gregora; R Pytlı́k; J Maaloufová; P Kobylka; S̆ 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Intravenous therapy for the treatment of

✍ Professor Michael Hutchinson; Karl Nichol; Mhairi Nellis; Jeanette Spicer; Elspe 📂 Article 📅 2008 🏛 Wiley (John Wiley & Sons) ⚖ 213 KB

148Immunoablative therapy with purified

✍ H.L. Atkins; M. Freedman; M. Bowman; J. Antel; D. Arnold; I. Bence-Bruckler; A. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Intravenous immunoglobulin (IVIG) for th

✍ D Poehlau; G Amoiridis; T Postert; S Schimrigk; I Nastos; L Schoels; H Przuntek 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Role of Immunosuppressive Therapy for th

✍ Stankiewicz, James M.; Kolb, Hadar; Karni, Arnon; Weiner, Howard L. 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 832 KB

Immune modulating peptides for the treat

✍ Ahmed H. Badawi; Teruna J. Siahaan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 420 KB